Literature DB >> 3535170

L-asparaginase effects on inhibition of protein synthesis and lowering of the glutamine content in cultured rat hepatocytes.

P Villa, M Corada, I Bartosek.   

Abstract

Primary cultures of rat hepatocytes were exposed to various concentrations of L-asparaginase derived from Escherichia Coli. Protein synthesis was inhibited by about 33% and cellular glutamine was reduced proportionally to the enzyme concentration. However, protein synthesis was inhibited only by amounts of enzyme able to reduce glutamine to critical levels below 10 nmol/mg cell protein. These data suggest that the glutaminase activity which probably contaminates E. coli asparaginase may be responsible for reduced liver protein synthesis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3535170     DOI: 10.1016/0378-4274(86)90113-x

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  11 in total

1.  Protein turnover, synthesis and secretion of albumin in hepatocytes isolated from rats bearing Walker 256 carcinoma.

Authors:  P Villa; P Arioli; A Guaitani
Journal:  In Vitro Cell Dev Biol       Date:  1992-03

2.  The glutaminase activity of L-asparaginase is not required for anticancer activity against ASNS-negative cells.

Authors:  Wai Kin Chan; Philip L Lorenzi; Andriy Anishkin; Preeti Purwaha; David M Rogers; Sergei Sukharev; Susan B Rempe; John N Weinstein
Journal:  Blood       Date:  2014-03-21       Impact factor: 22.113

Review 3.  A systematic review of selected musculoskeletal late effects in survivors of childhood cancer.

Authors:  Prasad L Gawade; Melissa M Hudson; Sue C Kaste; Joseph P Neglia; Karen Wasilewski-Masker; Louis S Constine; Leslie L Robison; Kirsten K Ness
Journal:  Curr Pediatr Rev       Date:  2014

Review 4.  Overview of the structure, side effects, and activity assays of l-asparaginase as a therapy drug of acute lymphoblastic leukemia.

Authors:  Nanxiang Wang; Wenhui Ji; Lan Wang; Wanxia Wu; Wei Zhang; Qiong Wu; Wei Du; Hua Bai; Bo Peng; Bo Ma; Lin Li
Journal:  RSC Med Chem       Date:  2022-01-12

5.  Skeletal Muscle and Childhood Cancer: Where are we now and where we go from here.

Authors:  Chelsea G Goodenough; Robyn E Partin; Kirsten K Ness
Journal:  Aging Cancer       Date:  2021-05-20

Review 6.  Asparagine synthetase: a new potential biomarker in ovarian cancer.

Authors:  Philip L Lorenzi; John N Weinstein
Journal:  Drug News Perspect       Date:  2009 Jan-Feb

7.  Personalized nanomedicine: a rapid, sensitive, and selective UV-vis spectrophotometry method for the quantification of nanostructured PEG-asparaginase activity in children's plasma.

Authors:  Yong Zhang; Yongren Wang; Ru Wang; Yan Shen; Jing Xu; Thomas J Webster; Yongjun Fang
Journal:  Int J Nanomedicine       Date:  2018-10-15

8.  Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1-driven acute lymphoblastic leukemia.

Authors:  Tra Ly Nguyen; Marie-Julie Nokin; Silvia Terés; Mercedes Tomé; Clément Bodineau; Oriane Galmar; Jean-Max Pasquet; Benoit Rousseau; Sebastian van Liempd; Juan Manuel Falcon-Perez; Elodie Richard; Elodie Muzotte; Hamid-Reza Rezvani; Muriel Priault; Marion Bouchecareilh; Isabelle Redonnet-Vernhet; Julien Calvo; Benjamin Uzan; Françoise Pflumio; Patricia Fuentes; Maria L Toribio; Abdel-Majid Khatib; Pierre Soubeyran; Piedad Del Socorro Murdoch; Raúl V Durán
Journal:  Mol Oncol       Date:  2021-02-13       Impact factor: 6.603

9.  Levocarnitine does not impair chemotherapy cytotoxicity against acute lymphoblastic leukemia.

Authors:  Jessica L Sea; Etan Orgel; Ting Chen; Rebecca L Paszkiewicz; Abigail S Krall; Matthew J Oberley; Linsey Stiles; Steven D Mittelman
Journal:  Leuk Lymphoma       Date:  2019-09-16

10.  A clinically attainable dose of L-asparaginase targets glutamine addiction in lymphoid cell lines.

Authors:  Koichi Sugimoto; Hiroshi I Suzuki; Tsutomu Fujimura; Asami Ono; Naoko Kaga; Yasushi Isobe; Makoto Sasaki; Hikari Taka; Kohei Miyazono; Norio Komatsu
Journal:  Cancer Sci       Date:  2015-10-16       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.